Wissenschaft & Forschung<\/a>","qubely_excerpt":"Die Entscheidung des Gemeinsamen Bundesausschusses (G-BA) vom 16.04.2026, den Zusatznutzen von Donanemab als \u201enicht belegt“ einzustufen, \u00fcberrascht die Projektleitung von digiDEM nicht. Bereits bei Lecanemab war der G-BA im Februar 2026 dieses Jahres zu diesem Ergebnis gekommen. Nun zeigt sich: Auch das zweite Medikament mit einem \u00e4hnlichen Wirkmechanismus kann keinen …","featured_image_urls_v2":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg",1600,1067,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-768x512.jpg",768,512,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1030x687.jpg",1030,687,true],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1536x1025.jpg",1536,1025,true],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-2048x1366.jpg",2048,1366,true],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1200x750.jpg",1200,750,true],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-525x350.jpg",525,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1320x880.jpg",1320,880,true],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1024x1024.jpg",1024,1024,true]},"post_excerpt_stackable_v2":"Die Entscheidung des Gemeinsamen Bundesausschusses (G-BA) vom 16.04.2026, den Zusatznutzen von Donanemab als \u201enicht belegt“ einzustufen, \u00fcberrascht die Projektleitung von digiDEM nicht. Bereits bei Lecanemab war der G-BA im Februar 2026 dieses Jahres zu diesem Ergebnis gekommen. Nun zeigt sich: Auch das zweite Medikament mit einem \u00e4hnlichen Wirkmechanismus kann keinen klinisch relevanten Nutzen nachweisen, der f\u00fcr die Betroffenen im Alltag sp\u00fcrbar w\u00e4re. Erschwerend kommt hinzu, dass f\u00fcr eine der beiden zugelassenen Patientengruppen trotz erg\u00e4nzender Auswertungsversuche des Herstellers keine geeignete Datenbasis vorlag, um den Zusatznutzen \u00fcberhaupt beurteilen zu k\u00f6nnen. Bei gesch\u00e4tzten Behandlungskosten von rund 25.000 Euro pro Jahr muss die Preisgestaltung…<\/p>\n","category_list_v2":"Aktuelles zu digiDEM<\/a>, Wissenschaft & Forschung<\/a>","author_info_v2":{"name":"Anne Keefer","url":"https:\/\/digidem-bayern.de\/en\/author\/ag-webinar\/"},"comments_num_v2":"0 comments","yoast_head":"\ndigiDEM Bayern-Statement zu Donanemab - digiDEM Bayern<\/title>\n<meta name=\"description\" content=\"Der Bayerische Landesapothekerkammer unterst\u00fctzt digiDEM Bayern mit Hilfe des Netzwerks "Demenzfreundliche Apotheken".\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/digidem-bayern.de\/en\/digidem-bayern-statement-zu-donanemab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"digiDEM Bayern-Statement zu Donanemab - digiDEM Bayern\" \/>\n<meta property=\"og:description\" content=\"Der Bayerische Landesapothekerkammer unterst\u00fctzt digiDEM Bayern mit Hilfe des Netzwerks "Demenzfreundliche Apotheken".\" \/>\n<meta property=\"og:url\" content=\"https:\/\/digidem-bayern.de\/en\/digidem-bayern-statement-zu-donanemab\/\" \/>\n<meta property=\"og:site_name\" content=\"digiDEM Bayern\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/digiDEMBayern\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T17:30:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-29T17:30:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1030x687.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1030\" \/>\n\t<meta property=\"og:image:height\" content=\"687\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anne Keefer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne Keefer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/\"},\"author\":{\"name\":\"Anne Keefer\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/0e8781e0653d1a8e57ca55bd2c3cb01f\"},\"headline\":\"digiDEM Bayern-Statement zu Donanemab\",\"datePublished\":\"2026-04-29T17:30:23+00:00\",\"dateModified\":\"2026-04-29T17:30:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/\"},\"wordCount\":152,\"commentCount\":0,\"publisher\":{\"@id\":\"\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Medikament_Infusion_Fluessig.jpg\",\"keywords\":[\"Demenz\",\"Demenz-Medikamente\",\"digidem\",\"Donanemab\",\"Medikamente\",\"Wohlbefinden\"],\"articleSection\":[\"Aktuelles zu digiDEM\",\"Wissenschaft & Forschung\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/\",\"name\":\"digiDEM Bayern-Statement zu Donanemab - digiDEM Bayern\",\"isPartOf\":{\"@id\":\"\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Medikament_Infusion_Fluessig.jpg\",\"datePublished\":\"2026-04-29T17:30:23+00:00\",\"dateModified\":\"2026-04-29T17:30:24+00:00\",\"description\":\"Der Bayerische Landesapothekerkammer unterst\u00fctzt digiDEM Bayern mit Hilfe des Netzwerks \\\"Demenzfreundliche Apotheken\\\".\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#primaryimage\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Medikament_Infusion_Fluessig.jpg\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Medikament_Infusion_Fluessig.jpg\",\"width\":1600,\"height\":1067},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/digidem-bayern-statement-zu-donanemab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/digidem-bayern.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"digiDEM Bayern-Statement zu Donanemab\"}]},{\"@type\":\"WebSite\",\"@id\":\"\\\/#website\",\"url\":\"\\\/\",\"name\":\"digiDEM Bayern\",\"description\":\"Das digitale Demenzregister Bayern erforscht und verbessert die Angebotsstuktur f\u00fcr Menschen mit Demenz und deren Angeh\u00f6rige\",\"publisher\":{\"@id\":\"\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"\\\/#organization\",\"name\":\"digiDEM Bayern\",\"url\":\"\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"width\":612,\"height\":357,\"caption\":\"digiDEM Bayern\"},\"image\":{\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/digiDEMBayern\\\/\",\"https:\\\/\\\/x.com\\\/digidem_bayern\",\"https:\\\/\\\/www.instagram.com\\\/digidem.bayern\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/digidem-bayern\\\/\"]},{\"@type\":\"Person\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/0e8781e0653d1a8e57ca55bd2c3cb01f\",\"name\":\"Anne Keefer\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/en\\\/author\\\/ag-webinar\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"digiDEM Bayern-Statement zu Donanemab - digiDEM Bayern","description":"Der Bayerische Landesapothekerkammer unterst\u00fctzt digiDEM Bayern mit Hilfe des Netzwerks \"Demenzfreundliche Apotheken\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/digidem-bayern.de\/en\/digidem-bayern-statement-zu-donanemab\/","og_locale":"en_US","og_type":"article","og_title":"digiDEM Bayern-Statement zu Donanemab - digiDEM Bayern","og_description":"Der Bayerische Landesapothekerkammer unterst\u00fctzt digiDEM Bayern mit Hilfe des Netzwerks \"Demenzfreundliche Apotheken\".","og_url":"https:\/\/digidem-bayern.de\/en\/digidem-bayern-statement-zu-donanemab\/","og_site_name":"digiDEM Bayern","article_publisher":"https:\/\/www.facebook.com\/digiDEMBayern\/","article_published_time":"2026-04-29T17:30:23+00:00","article_modified_time":"2026-04-29T17:30:24+00:00","og_image":[{"width":1030,"height":687,"url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1030x687.jpg","type":"image\/jpeg"}],"author":"Anne Keefer","twitter_misc":{"Written by":"Anne Keefer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#article","isPartOf":{"@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/"},"author":{"name":"Anne Keefer","@id":"\/#\/schema\/person\/0e8781e0653d1a8e57ca55bd2c3cb01f"},"headline":"digiDEM Bayern-Statement zu Donanemab","datePublished":"2026-04-29T17:30:23+00:00","dateModified":"2026-04-29T17:30:24+00:00","mainEntityOfPage":{"@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/"},"wordCount":152,"commentCount":0,"publisher":{"@id":"\/#organization"},"image":{"@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg","keywords":["Demenz","Demenz-Medikamente","digidem","Donanemab","Medikamente","Wohlbefinden"],"articleSection":["Aktuelles zu digiDEM","Wissenschaft & Forschung"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/","url":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/","name":"digiDEM Bayern-Statement zu Donanemab - digiDEM Bayern","isPartOf":{"@id":"\/#website"},"primaryImageOfPage":{"@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#primaryimage"},"image":{"@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg","datePublished":"2026-04-29T17:30:23+00:00","dateModified":"2026-04-29T17:30:24+00:00","description":"Der Bayerische Landesapothekerkammer unterst\u00fctzt digiDEM Bayern mit Hilfe des Netzwerks \"Demenzfreundliche Apotheken\".","breadcrumb":{"@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#primaryimage","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg","width":1600,"height":1067},{"@type":"BreadcrumbList","@id":"https:\/\/digidem-bayern.de\/digidem-bayern-statement-zu-donanemab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/digidem-bayern.de\/"},{"@type":"ListItem","position":2,"name":"digiDEM Bayern-Statement zu Donanemab"}]},{"@type":"WebSite","@id":"\/#website","url":"\/","name":"digiDEM Bavaria","description":"The digital dementia register in Bavaria researches and improves the structure of services for people with dementia and their relatives","publisher":{"@id":"\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"\/#organization","name":"digiDEM Bavaria","url":"\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"\/#\/schema\/logo\/image\/","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","width":612,"height":357,"caption":"digiDEM Bayern"},"image":{"@id":"\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/digiDEMBayern\/","https:\/\/x.com\/digidem_bayern","https:\/\/www.instagram.com\/digidem.bayern","https:\/\/www.linkedin.com\/company\/digidem-bayern\/"]},{"@type":"Person","@id":"\/#\/schema\/person\/0e8781e0653d1a8e57ca55bd2c3cb01f","name":"Anne Keefer","url":"https:\/\/digidem-bayern.de\/en\/author\/ag-webinar\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg",1600,1067,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-300x200.jpg",300,200,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-768x512.jpg",768,512,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1030x687.jpg",1030,687,true],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1536x1025.jpg",1536,1025,true],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-2048x1366.jpg",2048,1366,true],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig.jpg",18,12,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1200x750.jpg",1200,750,true],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-525x350.jpg",525,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1320x880.jpg",1320,880,true],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2026\/03\/Medikament_Infusion_Fluessig-1024x1024.jpg",1024,1024,true]},"uagb_author_info":{"display_name":"Anne Keefer","author_link":"https:\/\/digidem-bayern.de\/en\/author\/ag-webinar\/"},"uagb_comment_info":0,"uagb_excerpt":"Die Entscheidung des Gemeinsamen Bundesausschusses (G-BA) vom 16.04.2026, den Zusatznutzen von Donanemab als \u201enicht belegt“ einzustufen, \u00fcberrascht die Projektleitung von digiDEM nicht. Bereits bei Lecanemab war der G-BA im Februar 2026 dieses Jahres zu diesem Ergebnis gekommen. Nun zeigt sich: Auch das zweite Medikament mit einem \u00e4hnlichen Wirkmechanismus kann keinen …","_links":{"self":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/49087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/comments?post=49087"}],"version-history":[{"count":1,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/49087\/revisions"}],"predecessor-version":[{"id":49088,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/49087\/revisions\/49088"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media\/48605"}],"wp:attachment":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media?parent=49087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/categories?post=49087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/tags?post=49087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}